The Stakes for Effective Commercialization Have Never Been Higher
Why a clear and aligned vision for the brand across the product lifecycle matters early »
Click HereWhy a clear and aligned vision for the brand across the product lifecycle matters early »
Click HereColin completed his undergraduate degree in Physiology and Zoology from the University of Sheffield, UK and his PhD at the University of Hull, UK on the ultrasonic assessment of bone within the department of applied physics while employed as a research assistant to an orthopedic surgeon. Following his PhD, Colin worked at Syntex Pharmaceuticals (now part of Roche) and Procter & Gamble Pharmaceuticals before moving to the USA in 1994 to start a new company, Bona Fide Ltd. which was sold to Bio-Imaging Technologies (now BioClinica) 5 years later. He was instrumental in supporting the growth of BioClinica from 35 people to over 1,200 employees. As Vice President and later Senior Vice President Medical Affairs, he led sales for nearly 5 years, marketing for 7 years, and scientific/medical/regulatory oversight of the company for 12 years. This also included handling regulatory affairs, strategic development, and supporting clients with their communications with the FDA. Colin left Bioclinica in 2015 and joined Alacrita as a consultant and also started his own analytics company, BrackenData.
He has been involved in supporting clients to obtain marketing approval for numerous drugs/biologics and several devices across a range of therapeutic areas. In addition, he has been an advisor on several safety boards and advisory committees. He has presented at the FDA and attended meetings in the development of guidance documents, including the challenges with Progression Free Survival (PFS) in oncology.
Colin has over 70 peer reviewed publications and has published 3 books through Springer, the latest entitled “Medical Imaging in Clinical Trials” in 2014. He has 3 patents, all of which led to marketed products. He is a fellow of both the Institute of Clinical Research and the Institute of Physics and Engineering in Medicine and is a Chartered Scientist.
Jun is a seasoned executive with 20+ years sales, marketing, and analytics experience in the biopharmaceutical Industry. Jun is the founder of Cobbs Creek, a boutique consulting firm providing expertise in predictive analytics, sales forecasting, and sales/marketing resource optimization. Prior to Cobbs Creek, Jun worked at Verispan, Prism Pharmaceuticals, IMS, AstraZeneca, Sigma-Aldrich, Denville Scientific, and Harvard Medical School. Jun holds a BS in biology from Sun Yat-Sen University, an MBA from Harvard Business School, and a PhD in Biology from Bowling Green State University.